Instruments

Name Stock exchange Average volume Price Type
ALBERT DAVID LIMITED ALBERTDAVD

Bombay S.E. +1 Other

1,556 1,165 INR Stock Albert David Limited Stock
ALBERT DAVID LIMITED ALBERTDAVD

NSE India S.E.

9,047 1,167 INR Stock Albert David Limited
NINGBO DAVID MEDICAL DEVICE CO., LTD. 300314

Shenzhen S.E.

10,488,601 12.68 CNY Stock Ningbo David Medical Device Co., Ltd. Stock
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DAVID GEGEN GOLIATH - NUR AKTIEN LS9LPV

Berne S.E.

- - CHF Certificat ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DAVID GEGEN GOLIATH - NUR AKTIEN Certificat
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DAVID GEGEN GOLIATH - NUR AKTIEN

Börse Stuttgart

- 183.6 EUR Certificat ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DAVID GEGEN GOLIATH - NUR AKTIEN Certificat

News (231)

BioMarin Pharmaceutical : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K PU
Philips : Report of the Remuneration Committee 2023 PU
Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen's Association AQ
Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen’s Association BU
Results of Philips’ 2023 Annual General Meeting of Shareholders GL
Philips convenes the Annual General Meeting of Shareholders 2023 AQ
Philips : Binding list of nominees AGM 2023 PU
Philips convenes the Annual General Meeting of Shareholders 2023 GL
Philips convenes the Annual General Meeting of Shareholders 2023 AQ
BIOMARIN PHARMACEUTICAL INC : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
ALNYLAM PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Transcript : Koninklijke Philips N.V. - Shareholder/Analyst Call
Transcript : Bioniz Therapeutics, Inc., Equillium, Inc. - M&A Call
Equillium : Acquires Bioniz Therapeutics Significantly Expanding Pipeline of Novel Immunomodulatory Drug Candidates - Form 8-K PU
Equillium Acquires Bioniz Therapeutics Significantly Expanding Pipeline of Novel Immunomodulatory Drug Candidates BU
Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement of the Alnylam Pharmaceuticals, Inc. Securities Litigation PR
PLIANT THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
BIOMARIN PHARMACEUTICAL INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K) AQ
New Center for Higher Ambition Leadership CEO Jeannie Diefenderfer Shares Bold Vision to Increase Reach and Impact of the Nonprofit PR
Transcript : BioMarin Pharmaceutical Inc. - Shareholder/Analyst Call
ALNYLAM PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Transcript : Alnylam Pharmaceuticals, Inc. - Shareholder/Analyst Call
Pliant Therapeutics : Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results AQ
PLIANT THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) AQ
Pliant Therapeutics : Announces Appointment of David Pyott to Board of Directors AQ
Pliant Therapeutics, Inc. Announces Appointment of David Pyott to Board of Directors CI
Easterseals Disability Film Challenge: Home Edition Winners Announced at a Star-Studded Awards Ceremony BU
BIOMARIN PHARMACEUTICAL INC : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
Transcript : BioMarin Pharmaceutical Inc. - Shareholder/Analyst Call
BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines GL
Transcript : Koninklijke Philips N.V. - Shareholder/Analyst Call
Transcript : Avery Dennison Corporation - Shareholder/Analyst Call
SABIN VACCINE INSTITUTE STRENGTHENS EBOLA SUDAN AND MARBURG VACCINES PROGRAM WITH ADDITIONAL NIAID PARTNERSHIP GL
AVERY DENNISON CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) AQ
Avery Dennison : Announces Change in Board Leadership Structure BU
Avery Dennison Corporation Announces Board Changes CI
Alnylam Pharmaceuticals : SEC Filing - S-8 PU
“The Good Doctor,” “New Amsterdam,” “NCIS: New Orleans,” “The Peanut Butter Falcon” and Actor Nyle DiMarco Announced as Honorees for Annual Media Access Awards GL
Sabin Vaccine Institute Receives $20.5 Million From BARDA With Potential of up to $128 Million to Develop Ebola Sudan and Marburg Vaccines GL
GSK Grants Exclusive Technology License for Clinical-Stage Ebola Vaccines to Sabin Vaccine Institute GL
Orbis : Secures USD $2 Million Funding from the David and Molly Pyott Foundation to Strengthen Eye Health in Zambia PR
Transcript : Allergan plc Presents at Jefferies 2019 Healthcare Conference, Jun-06-2019 02:00 PM
Entertainment Industry Unites for Easterseals Disability Film Challenge Awards to Honor Filmmakers Who Inspire Change GL
Finalists for the Easterseals Disability Film Challenge Announced and Showcased at the Newport Beach Film Festival GL
Transcript : Alnylam Pharmaceuticals, Inc. - Shareholder/Analyst Call
1234NextSee all

Companies (31)

DAVIDE CAMPARI-MILANO N.V. 12 660 M $
Logo Davide Campari-Milano N.V.

Davide Campari-Milano N.V. is one of the Italian's leading producers and distributors of spirits and wines. The activity is organized around three product families: - spirits: rhums, vodkas, tequilas, whiskies, liqueurs, etc. (Campari, SKYY Vodka, Cynar, ...

DAVIDE CAMPARI-MILANO N.V. 12 660 M $
Logo Davide Campari-Milano N.V.

Davide Campari-Milano N.V. is one of the Italian's leading producers and distributors of spirits and wines. The activity is organized around three product families: - spirits: rhums, vodkas, tequilas, whiskies, liqueurs, etc. (Campari, SKYY Vodka, Cynar, ...

BARRATT DEVELOPMENTS PLC 5 986 M $
Logo Barratt Developments PLC

Barratt Developments PLC is one of the leading British builders of single-family homes. The group also develops and manages real estate properties. Net sales break down by activity as follows: - construction and sales of houses (98.4%): 17,206 houses bui ...

BARRATT DEVELOPMENTS PLC 5 986 M $
Logo Barratt Developments plc

Barratt Developments PLC is one of the leading British builders of single-family homes. The group also develops and manages real estate properties. Net sales break down by activity as follows: - construction and sales of houses (98.4%): 17,206 houses bui ...

DAN HOTELS LTD 581 M $
Logo Dan Hotels Ltd

Dan Hotels Ltd is an Israel-based hotel chain which owns and operates 14 hotels throughout Israel, with a total of 3,874 rooms.The majority of the Dan Hotels are graded by the Ministry of Tourism as First Class hotels, the remainder as Tourist Class hotel ...

MAGGIE BEER HOLDINGS LIMITED 17 M $
Logo Maggie Beer Holdings Limited

Maggie Beer Holdings Ltd is engaged in sale of branded premium food and beverage and gifting products in Australia and overseas markets. Its segments Maggie Beer Products Pty Ltd (MBP), Hampers & Gifts Australia Pty Ltd (HGA), and B.-d Farm Paris Creek Pt ...

ALBA MINERAL RESOURCES PLC 7 M $
Logo Alba Mineral Resources plc

Alba Mineral Resources plc is engaged in the exploration and development of natural resources. The Company's mineral exploration portfolio is comprised of gold and, graphite, ilmenite, base metal and iron ore projects in a cluster of countries in northern ...

PRIME STRATEGY CO., LTD. 31 M $
Logo Prime Strategy Co., Ltd.

Prime Strategy Co Ltd is a Japan-based company mainly engaged in the KUSANAGI Stack business. The KUSANAGI Stack Business segment consists of three main services: KUSANAGI Managed Services, Cloud Integration Services, and License Sales. The Company is als ...

RATIO ENERGIES - LIMITED PARTNERSHIP 886 M $
Logo Ratio Energies - Limited Partnership

Ratio Energies LP,formerly known as Ratio Oil Exploration 1992 LP is an Israel-based company. The Company holds two plots in which it is actively exploring for gas and petroleum. In addition, the Company has a partnership in a few exploration fields: Mad ...

AUTEK CHINA INC. 2 359 M $
Logo Autek China Inc.

Autek China Inc is a China-based company principally engaged in the research and development, production and sales of eye-sight products and the provision of eye-sight services. The Company's main business is non-surgical vision correction. The Company's ...


1234Next

Insiders

Picture David Pyott
David Pyott

David E. I. Pyott is a British businessperson who has been at the head of 7 different companies. Presently, he occupies the position of Chairman of Bioniz Therapeutics, Inc., Chief Executive Officer & Director at Serica Technologies, Inc. and President of Vicept Therapeutics, Inc. Dr. Pyott is also President at International Council of Ophthalmology Foundation and on the board of 13 other companies. David E. I. Pyott previously was Head-Nutrition Division at Novartis AG and President & Chief Executive Officer for Sandoz Nutrition Corp. (a subsidiary of Novartis AG), Chairman & Chief Executive Officer at Allergan, Inc. and Chairman for California Healthcare Institute. He received a graduate degree from The University of Edinburgh and an MBA from London Business School.




Picture Alison Lyn Pyott
Alison Lyn Pyott

Ms. Alison L.
Pyott is Partner at Veris Wealth Partners LLC.
She is also a Senior Wealth Manager of the Veris Portsmouth office.
She manages client portfolios and designs comprehensive strategies to meet a wide range of clients’ financial and impact goals.
She currently serves as the Treasurer for the New Hampshire Women’s Foundation and Chair for New Hampshire Charitable Foundation – Piscataqua Region Advisory Board.
She is also a member of the Seacoast Women’s Giving Circle, New England International Donors, and the Financial Planning Association of New England.
She has over 20 years of financial services experience.
Prior to Veris, Ms. Pyott was the Director of Client and Shareholder Services for Citizens Advisors, a socially responsible mutual fund company.
She also worked in client service and management positions at John Hancock Signature Services.
She worked for the United Way of the Greater Seacoast, where she managed community investment and outcome measurement programs.
She graduated from University of New Hampshire’s Whittemore School of Business and Economics with a B.S.
in Hotel Administration and from Merrimack College with a Certificate in Financial Planning.


No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW